Go Pro
→ Trump Takes Emergency Action - Plus Elon Musk's New Venture (From Altimetry) (Ad)tc pixel Free AREC Stock Alerts

Arecor Therapeutics (AREC) Competitors

Arecor Therapeutics logo
GBX 62 +3.50 (+5.98%)
As of 10:23 AM Eastern
Compare

AREC vs. AURA, NEO, NCCL, ARMS, and BHR

Should you buy Arecor Therapeutics stock or one of its competitors? Arecor Therapeutics's main competitors and comparable companies include Aura Energy (AURA), Neo Energy Metals (NEO), Ncondezi Energy (NCCL), Asia Resource Minerals (ARMS), and Beacon Hill Resources (BHR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "coal & consumable fuels" industry.

How does Arecor Therapeutics compare to Aura Energy?

Aura Energy (LON:AURA) and Arecor Therapeutics (LON:AREC) are both small-cap energy companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, dividends, profitability, analyst recommendations, institutional ownership and risk.

Arecor Therapeutics has a net margin of 38.74% compared to Aura Energy's net margin of 0.00%. Arecor Therapeutics' return on equity of 14.26% beat Aura Energy's return on equity.

Company Net Margins Return on Equity Return on Assets
Aura EnergyN/A -17.87% -8.03%
Arecor Therapeutics 38.74%14.26%-37.31%

Aura Energy has higher earnings, but lower revenue than Arecor Therapeutics. Aura Energy is trading at a lower price-to-earnings ratio than Arecor Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aura EnergyN/AN/A-£16.15K-£1.11N/A
Arecor Therapeutics£1.71M13.66-£10.68M£2.0031.00

Aura Energy has a beta of -0.35, meaning that its share price is 135% less volatile than the broader market. Comparatively, Arecor Therapeutics has a beta of -0.18, meaning that its share price is 118% less volatile than the broader market.

12.5% of Aura Energy shares are owned by institutional investors. Comparatively, 6.0% of Arecor Therapeutics shares are owned by institutional investors. 5.9% of Aura Energy shares are owned by company insiders. Comparatively, 4.8% of Arecor Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Aura Energy had 2 more articles in the media than Arecor Therapeutics. MarketBeat recorded 2 mentions for Aura Energy and 0 mentions for Arecor Therapeutics. Aura Energy's average media sentiment score of 0.77 beat Arecor Therapeutics' score of 0.00 indicating that Aura Energy is being referred to more favorably in the media.

Company Overall Sentiment
Aura Energy Positive
Arecor Therapeutics Neutral

Summary

Aura Energy and Arecor Therapeutics tied by winning 6 of the 12 factors compared between the two stocks.

How does Arecor Therapeutics compare to Neo Energy Metals?

Neo Energy Metals (LON:NEO) and Arecor Therapeutics (LON:AREC) are both small-cap energy companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, media sentiment, institutional ownership, dividends, risk and profitability.

In the previous week, Neo Energy Metals' average media sentiment score of 0.00 equaled Arecor Therapeutics'average media sentiment score.

Company Overall Sentiment
Neo Energy Metals Neutral
Arecor Therapeutics Neutral

Neo Energy Metals has higher earnings, but lower revenue than Arecor Therapeutics. Neo Energy Metals is trading at a lower price-to-earnings ratio than Arecor Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Neo Energy MetalsN/AN/A-£4.24M£0.184.81
Arecor Therapeutics£1.71M13.66-£10.68M£2.0031.00

Neo Energy Metals has a beta of 4.995, meaning that its stock price is 400% more volatile than the broader market. Comparatively, Arecor Therapeutics has a beta of -0.18, meaning that its stock price is 118% less volatile than the broader market.

Arecor Therapeutics has a net margin of 38.74% compared to Neo Energy Metals' net margin of 0.00%. Arecor Therapeutics' return on equity of 14.26% beat Neo Energy Metals' return on equity.

Company Net Margins Return on Equity Return on Assets
Neo Energy MetalsN/A -503.60% N/A
Arecor Therapeutics 38.74%14.26%-37.31%

3.5% of Neo Energy Metals shares are owned by institutional investors. Comparatively, 6.0% of Arecor Therapeutics shares are owned by institutional investors. 40.8% of Neo Energy Metals shares are owned by insiders. Comparatively, 4.8% of Arecor Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Arecor Therapeutics beats Neo Energy Metals on 6 of the 10 factors compared between the two stocks.

How does Arecor Therapeutics compare to Ncondezi Energy?

Ncondezi Energy (LON:NCCL) and Arecor Therapeutics (LON:AREC) are both small-cap energy companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation.

Ncondezi Energy has a beta of 1.05, indicating that its stock price is 5% more volatile than the broader market. Comparatively, Arecor Therapeutics has a beta of -0.18, indicating that its stock price is 118% less volatile than the broader market.

In the previous week, Ncondezi Energy's average media sentiment score of 0.00 equaled Arecor Therapeutics'average media sentiment score.

Company Overall Sentiment
Ncondezi Energy Neutral
Arecor Therapeutics Neutral

9.7% of Ncondezi Energy shares are held by institutional investors. Comparatively, 6.0% of Arecor Therapeutics shares are held by institutional investors. 34.3% of Ncondezi Energy shares are held by company insiders. Comparatively, 4.8% of Arecor Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Arecor Therapeutics has a net margin of 38.74% compared to Ncondezi Energy's net margin of 0.00%. Arecor Therapeutics' return on equity of 14.26% beat Ncondezi Energy's return on equity.

Company Net Margins Return on Equity Return on Assets
Ncondezi EnergyN/A -15.23% -5.36%
Arecor Therapeutics 38.74%14.26%-37.31%

Ncondezi Energy has higher earnings, but lower revenue than Arecor Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ncondezi EnergyN/AN/A-£2.05MN/AN/A
Arecor Therapeutics£1.71M13.66-£10.68M£2.0031.00

Summary

Ncondezi Energy beats Arecor Therapeutics on 5 of the 9 factors compared between the two stocks.

How does Arecor Therapeutics compare to Asia Resource Minerals?

Arecor Therapeutics (LON:AREC) and Asia Resource Minerals (LON:ARMS) are both energy companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, institutional ownership, risk, analyst recommendations, media sentiment and profitability.

In the previous week, Arecor Therapeutics' average media sentiment score of 0.00 equaled Asia Resource Minerals'average media sentiment score.

Company Overall Sentiment
Arecor Therapeutics Neutral
Asia Resource Minerals Neutral

Asia Resource Minerals has lower revenue, but higher earnings than Arecor Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Arecor Therapeutics£1.71M13.66-£10.68M£2.0031.00
Asia Resource MineralsN/AN/AN/AN/AN/A

6.0% of Arecor Therapeutics shares are held by institutional investors. 4.8% of Arecor Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Arecor Therapeutics has a net margin of 38.74% compared to Asia Resource Minerals' net margin of 0.00%. Arecor Therapeutics' return on equity of 14.26% beat Asia Resource Minerals' return on equity.

Company Net Margins Return on Equity Return on Assets
Arecor Therapeutics38.74% 14.26% -37.31%
Asia Resource Minerals N/A N/A N/A

Summary

Arecor Therapeutics beats Asia Resource Minerals on 5 of the 6 factors compared between the two stocks.

How does Arecor Therapeutics compare to Beacon Hill Resources?

Arecor Therapeutics (LON:AREC) and Beacon Hill Resources (LON:BHR) are both energy companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, media sentiment, analyst recommendations and dividends.

6.0% of Arecor Therapeutics shares are held by institutional investors. 4.8% of Arecor Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Arecor Therapeutics has a net margin of 38.74% compared to Beacon Hill Resources' net margin of 0.00%. Arecor Therapeutics' return on equity of 14.26% beat Beacon Hill Resources' return on equity.

Company Net Margins Return on Equity Return on Assets
Arecor Therapeutics38.74% 14.26% -37.31%
Beacon Hill Resources N/A N/A N/A

Beacon Hill Resources has lower revenue, but higher earnings than Arecor Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Arecor Therapeutics£1.71M13.66-£10.68M£2.0031.00
Beacon Hill ResourcesN/AN/AN/AN/AN/A

In the previous week, Arecor Therapeutics' average media sentiment score of 0.00 equaled Beacon Hill Resources'average media sentiment score.

Company Overall Sentiment
Arecor Therapeutics Neutral
Beacon Hill Resources Neutral

Summary

Arecor Therapeutics beats Beacon Hill Resources on 5 of the 6 factors compared between the two stocks.

Get Arecor Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for AREC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AREC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AREC vs. The Competition

Export
MetricArecor TherapeuticsOil, Gas & Consumable Fuels IndustryEnergy SectorLON Exchange
Market Cap£23.41M£11.01B£9.62B£2.88B
Dividend YieldN/A11.36%11.60%6.09%
P/E Ratio31.0016.4320.05368.35
Price / Sales13.66451.42370.2183,691.32
Price / Cash5.0739.6736.0827.89
Price / Book3.743.122.947.32
Net Income-£10.68M£5.27B£4.32B£5.89B
7 Day Performance0.81%2.35%2.51%1.51%
1 Month Performance-4.53%4.97%4.68%2.50%
1 Year PerformanceN/A35.46%38.35%73.97%

Arecor Therapeutics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AREC
Arecor Therapeutics
N/AGBX 62
+6.0%		N/A-3.5%£23.41M£1.71M31.0010
AURA
Aura Energy
N/AGBX 5.89
-1.9%		N/A-24.9%£60.03MN/AN/A50
NEO
Neo Energy Metals
N/AGBX 0.87
+8.8%		N/AN/A£24.30MN/A4.782,100
NCCL
Ncondezi Energy
N/AN/AN/AN/A£4.67MN/AN/A4
ARMS
Asia Resource Minerals
N/AN/AN/AN/A£0.00N/AN/A147,000

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:AREC) was last updated on 8/11/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel